Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 200.79

-0.2%

Nov 14 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Flagrante Delictu who wrote (18647)	4/5/1998 4:11:00 PM
From: Proton	Read Replies (3) of 32384

Re: Tamoxifen (On Topic, but who can tell?) This morning, NBC news is reporting that as a result of a 6 year test, Tamoxifen has been shown to be the first agent to show proof of breast cancer prevention. We believe that LGND's Targretin is an even better prevention agent, though it has yet to complete enough testing to gain the same recognition. Recognition is all in the stock market. Tamoxifen has a major clinical study to back up its prevention claims; Targretin does not. Furthermore, Tamoxifen is first past the prevention post. Cognitive primacy matters. Will this news cause a drop in LGND? I don't know. Is this news supportive to LGND? No, and the "Halo Effect" be damned. Pý p.s. Thank goodness for the Tamoxifen news, as it prevented this thread from falling into complete irrelevance (as it is, the signal-to-noise ratio has collapsed faster than the won or ringgit). Of course, that is the true agenda of the scurrilous, and replying merely encourages their continued blathering.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next